Drug Industry

Order of the National Green Tribunal regarding an illegal cracker unit in Thanjavur district, Tamil Nadu, 29/05/2025

Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …

UP wakes to drug-resistant TB challenge

LUCKNOW: Every second Indian undergoing treatment for tuberculosis comes from Uttar Pradesh. Considering that 17% of tuberculosis (TB) patients eventually become resistant to basic anti-TB treatment, the risk of multi drug resistant TB (MDR TB) looms large over the state. However, this was probably not enough to put health authorities …

Pharma firms’ effluents not treated properly

The findings of Andhra Pradesh Pollution Control Board, soon to be tabled before the state Assembly, show the presence of several active pharmaceutical ingredients in the effluent released by bulk drug units at Patancheru. APPCB has entrusted NEERI, Nagpur, to collect and analysis samples from the Central Effluent Treating Plant …

Vetting pharma M&As out of ambit, says CCI

New Delhi: The government’s move to get all acquisition of local pharmaceutical companies by overseas players vetted by the Competition Commission of the India (CCI) has run into trouble. CCI, the anti-monopoly watchdog, has told the government that the law does not empower it to monitor and restrict merger or …

Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: A database analysis

Reed Beall and Randall Kuhn describe their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995. Original Source

Drug Cos told to pay 4,000cr Penalty

Bombay HC refuses to stay 1996 notice to 500 companies on overcharging for bulk drugs More than 500 Indian drug companies will have to collectively pay over . 4,000 crore in dues after a high court shot down their petition challenging penalty notices sent by drug authorities for overcharging. Special …

Made in China

Although modern medicine is established in Asia, traditional medicine also plays a big role in people's healthcare — and is gaining in popularity in other countries too.

Protecting China's national treasure

The very nature of traditional Chinese medicine (TCM) poses serious challenges in patenting intellectual property. Unlike modern medicines, which are based on newly discovered, developed or isolated chemical compounds, TCM prescriptions typically consist of mixtures of well-known plant or animal extracts. Moreover, these recipes are public knowledge, having been recorded …

Ranbaxy to pay US FDA $500m

Mumbai: Japanese drug major Daiichi has lowered its profit forecast for the year ending March 2012, and slashed senior executive pay, to offset the impending loss arising out of its Indian subsidiary, Ranbaxy’s $500-million legal settlement in the US. After months of sticky negotiations, Ranbaxy finally announced on Wednesday that …

Drugmakers Look to Break Rural Deadlock: Novartis, GlaxoSmithKline, Pfizer & Ranbaxy focus on hinterland

Sample this: India’s rural market accounts for half of two-wheeler sales, a third each of fast-moving consumer goods sales and telephone subscriptions and 60% of gold consumption. In contrast, the drug industry in spite of the importance of medicine still sees the rural market accounting for just 20% of its …

New Drug Policy Draft Faces Public Heat

Stakeholders fear price cap formula will increase cost of medicines KHOMBA SINGH NEW DELHI The government’s new drug pricing policy draft is facing stiff all-round opposition over fears that it will increase prices of medicines, though manufacturers have welcomed it albeit with some changes. The draft National Pharmaceuticals Pricing Policy …

MoU to be signed on drug regulations

During Prime Minister Manmohan Singh’s three-day Russia visit, drug controllers of the two nations will sign a memorandum of understanding under which they will share information about drug adverse effects and regulation frameworks. The partnership could go on to recognise each other’s drug approval processes. India does not have too …

New rules seek compensation for clinical trial deaths

Faced with criticism on its clinical trial regulations, the Ministry of Health and Family Welfare has undertaken a slew of measures to streamline them, the most important being a proposed change in the rules of the Drugs and Cosmetics Rules 1945, which mandaates that in case of a death or …

WHO suspends procurement of hep-B vaccine from Bharat Biotech

The World Health Organisation has suspended the procurement of the hepatitis B vaccine – Revac B – from the Hyderabad-based vaccine-maker Bharat Biotech International Ltd. According to an alert released by the WHO, the decision was taken after a site audit of Bharat Biotech facility here conducted in September showed …

WHO suspends Bharat Biotech vaccine supply

Hyderabad Not too long after the delisting episode of Shanta Biotech’s pentavalent hepatitis B vaccine Shan5, the World Health Organization (WHO) has now suspended the supply of hepatitis B vaccine (Revac-B+) manufactured by Bharat Biotech International (BBIL). It has also terminated the prequalification procedures for current applications for other vaccines …

Health ministry not for market-based drug pricing suggested in pharma policy

Wants to take control of medicine price regulator from the chemicals ministry. The health ministry may oppose the market-based price fixing model suggested in the draft National Pharmaceutical Pricing Policy (NPPP). The ministry is of the opinion that a market-based pricing strategy, which in a broad sense takes the average …

Towards healthcare for all

Can we grasp an opportunity to provide health services to all Indians? (Editorial)

Intrigue in white lab coats

The Lipitor incident provides us with some insight into the pharmaceutical world, where science rubs shoulders with greed and intrigue On Wednesday, Ranbaxy put out an advertisement in the newspapers thanking everyone for their support in developing and launching atorvastatin in the US, which is the generic equivalent of Pfizer’s …

Hawking Poison

What Short-acting barbiturate used as an anaesthetic. First of a standard three-drug protocol used in the United States to execute prisoners sentenced to death. Lethal dose (up to 5 grams) used to render prisoner unconscious, after which a paralytic and a toxic agent injected in sequence. Why Shortage of sodium …

Ranbaxy launches generic Lipitor

Cholesterol Drug Hits US Stores The Day Pfizer Loses Patent Protection Mumbai: India’s largest drug company, Ranbaxy, which had been chasing a dream for years to launch the first generic version of world’s top-selling medicine Lipitor in the US, has finally succeeded—and, that too, as per schedule. Ending months of …

Where West meets East

The concepts of Asia's traditional medicines might sound alien to Western ears, but some of them are starting to evolve to fit scientific investigation.

  1. 1
  2. ...
  3. 25
  4. 26
  5. 27
  6. 28
  7. 29
  8. ...
  9. 73

IEP child categories loading...